3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
12
Small Cell Lung Carcinoma
11
Fallopian Tube Neoplasms
9
Neuroblastoma
6
Neoplasm Metastasis
3
Lung Neoplasms
3
Ganglioneuroblastoma
3
Carcinoma, Ovarian Epithelial
3
Uterine Cervical Neoplasms
2
Sarcoma, Ewing
2
Rhabdoid Tumor
2
Recurrence
2
Leukemia, Myeloid, Acute
2
Glioma
2
Central Nervous System Neoplasms
2
Wilms Tumor
1
Thrombocythemia, Essential
1
SCLC
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Pleuropulmonary blastoma
1
Peritoneal Neoplasms
1
Pediatric Brain Tumor
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neoplasms
1
Myelodysplastic-Myeloproliferative Diseases
1
Lymphoma, Follicular
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Interventions
Rituximab
9
venetoclax
7
ibrutinib
7
Cyclophosphamide
7
Mycophenolic Acid
5
fludarabine phosphate
4
Whole-Body Irradiation
4
Sirolimus
4
zanubrutinib
3
pirtobrutinib
3
Peripheral Blood Stem Cell Transplantation
3
Dexamethasone
3
Cyclosporine
3
ixazomib
2
fludarabine
2
carfilzomib
2
acalabrutinib
2
Tacrolimus
2
Melphalan
2
Etoposide
2
Cyclosporins
2
Calcium Dobesilate
2
CT-P10
2
Busulfan
2
Bendamustine Hydrochloride
2
talquetamab
1
pembrolizumab
1
loncastuximab tesirine
1
brexucabtagene autoleucel
1
Vincristine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Waldenstrom Macroglobulinemia
×
Topotecan
×
90 days
×
Clear all
No trials found.